Cargando…

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study

BACKGROUND: Several studies have investigated the relationship between psoriasis and adverse cardiovascular outcomes. Previous meta-analyses have shown psoriasis to be a risk factor for adverse cardiovascular outcomes. However, the relationship has become uncertain with the emergence of many new stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lu, Cui, Saijin, Liu, Meitong, Huo, Xiangran, Zhang, Guoqiang, Wang, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990932/ https://www.ncbi.nlm.nih.gov/pubmed/35402553 http://dx.doi.org/10.3389/fcvm.2022.829709

Ejemplares similares

Corrigendum: Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis
por: Liu, Meitong, et al.
Publicado: (2022)

CD39-Expressing CD8(+) T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
por: Liu, Meitong, et al.
Publicado: (2023)

Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases
por: D'Agostino, Marco, et al.
Publicado: (2022)

Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis
por: Zhang, Guanwei, et al.
Publicado: (2023)

Association between psoriasis and coronary artery calcification: A systematic review and meta-analysis
por: Wu, Huihui, et al.
Publicado: (2022)

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Lee, Jane J., et al.
Publicado: (2021)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis
por: Li, Sicong, et al.
Publicado: (2022)

Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Yifang, et al.
Publicado: (2023)

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
por: Akyea, Ralph K, et al.
Publicado: (2020)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants
por: Huang, Mingyan, et al.
Publicado: (2022)

Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
por: Liu, Yifei, et al.
Publicado: (2023)

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes
por: Fan, Jie-Fu, et al.
Publicado: (2023)

Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study
por: Boreskie, Kevin F, et al.
Publicado: (2017)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

The Association Between Monocyte Subsets and Cardiometabolic Disorders/Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Oh, Ester S., et al.
Publicado: (2021)

Serum oestradiol levels and risk of adverse cardiovascular events associated with gender-affirming oestrogen therapy: a protocol for a systematic review and meta-analysis
por: Rytz, Chantal L, et al.
Publicado: (2022)

The Predictive Value of Myoglobin for COVID-19-Related Adverse Outcomes: A Systematic Review and Meta-Analysis
por: Ma, Chaoqun, et al.
Publicado: (2021)

The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Quek, Jingxuan, et al.
Publicado: (2021)

Study title: A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use
por: Kim, Mimi M., et al.
Publicado: (2023)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Obesity increases cardiovascular mortality in patients with HFmrEF
por: Liu, Zhican, et al.
Publicado: (2022)

Association between maternal adversity, DNA methylation, and cardiovascular health of offspring: a longitudinal analysis of the ALSPAC cohort study
por: Hyde, Natalie K, et al.
Publicado: (2022)

Visit-to-Visit Heart Rate Variability Is Positively Associated With the Risk of Adverse Cardiovascular Outcomes
por: Zeng, Rong, et al.
Publicado: (2022)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: Findings from behavioral risk factor surveillance system, 2020
por: Liu, Xingyou, et al.
Publicado: (2022)

Editorial: The biological impact of adversity on cardiovascular disease risk and obesity
por: Baumer, Yvonne, et al.
Publicado: (2022)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
por: Wu, Si, et al.
Publicado: (2022)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis
por: Kosciuszek, Nina D., et al.
Publicado: (2022)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Yucong, et al.
Publicado: (2021)

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis
por: Ye, Zhen, et al.
Publicado: (2022)

Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis
por: Yu, Junwen, et al.
Publicado: (2023)

Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies
por: Ding, Kejun, et al.
Publicado: (2022)

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
por: Yu, Yani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hf7oqp1an1oduvl6vfls6jh1m